Literature DB >> 274175

Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in neoplastic and normal cells.

G J Lauzon, A R Paterson, A W Belch.   

Abstract

1-beta-D-Arabinofuranosylcytosine diphosphate choline was formed from 1-beta-D-arabinofuranosylcytosine (ara-C) during incubation in vitro of peripheral myeloblasts from patients with acute myelogenous leukemia and cultured cells (nonleukemic human lymphocytes, mouse lymphoma L5178Y, and HeLa); as well, 1-beta-D-arabinofuranosylcytosine diphosphate choline was formed in vivo in mouse leukemia L1210 cells and mouse liver. 3-Deazauridine enhanced the anabolism of ara-C in nonleukemic lymphocytes in vitro and leukemia L1210 cells in vivo but did not influence ara-C anabolism in the other cell types. In acute myelogenous leukemia myeloblasts incubated in vitro with ara-C, concentrations of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate were maximal after 8 hr of incubation and formation of the latter preceded that of 1-beta-D-arabinofuranosylcytosine diphosphate choline.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 274175

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

1.  Effect of uracil arabinoside on metabolism and cytotoxicity of cytosine arabinoside in L5178Y murine leukemia.

Authors:  J L Yang; E H Cheng; R L Capizzi; Y C Cheng; T Kute
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

Review 2.  Marine Anticancer Agents: An Overview with a Particular Focus on Their Chemical Classes.

Authors:  Marilia Barreca; Virginia Spanò; Alessandra Montalbano; Mercedes Cueto; Ana R Díaz Marrero; Irem Deniz; Ayşegül Erdoğan; Lada Lukić Bilela; Corentin Moulin; Elisabeth Taffin-de-Givenchy; Filippo Spriano; Giuseppe Perale; Mohamed Mehiri; Ana Rotter; Olivier P Thomas; Paola Barraja; Susana P Gaudêncio; Francesco Bertoni
Journal:  Mar Drugs       Date:  2020-12-04       Impact factor: 5.118

3.  The pharmacologic basis for the efficacy of high-dose Ara-C and sequential asparaginase in adult acute myelogenous leukemia.

Authors:  R L Capizzi; C White
Journal:  Yale J Biol Med       Date:  1988 Jan-Feb

4.  Optimization of cytarabine (ARA-C) therapy for acute myeloid leukemia.

Authors:  Richard L Momparler
Journal:  Exp Hematol Oncol       Date:  2013-08-06

5.  Gemcitabine diphosphate choline is a major metabolite linked to the Kennedy pathway in pancreatic cancer models in vivo.

Authors:  T E Bapiro; K K Frese; A Courtin; J L Bramhall; B Madhu; N Cook; A Neesse; J R Griffiths; D A Tuveson; D I Jodrell; F M Richards
Journal:  Br J Cancer       Date:  2014-05-29       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.